Saltar al contenido
Merck

Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors.

Bioorganic & medicinal chemistry (2013-12-19)
Erica Amato, Tony Bankemper, Rebecca Kidney, Thuy Do, Alma Onate, Fathima Shazna Thowfeik, Edward J Merino, Stefan Paula, Lili Ma
RESUMEN

Fluorinated isoflavanones and bifunctionalized isoflavanones were synthesized through a one-step gold(I)-catalyzed annulation reaction. These compounds were evaluated for their in vitro inhibitory activities against aromatase in a fluorescence-based enzymatic assay. Selected compounds were tested for their anti-proliferative effects on human breast cancer cell line MCF-7. Compounds 6-methoxy-3-(pyridin-3-yl)chroman-4-one (3c) and 6-fluoro-3-(pyridin-3-yl)chroman-4-one (3e) were identified as the most potent aromatase inhibitors with IC₅₀ values of 2.5 μM and 0.8 μM. Therefore, these compounds have great potential for the development of pharmaceutical agents against breast cancer.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
β-Estradiol, ≥98%